Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![Celldex Therapeutics, Inc Graphic](https://lunarcrush.com/gi/w:26/t:$cldx.png) Celldex Therapeutics, Inc (CLDX)

Barclays initiates coverage on Celldex Therapeutics with an Underweight rating and a $XX target. Despite the negative rating, positive trial data and analyst ratings are driving a bullish sentiment.

### About Celldex Therapeutics, Inc
Celldex Therapeutics, Inc. (CLDX) is a biotechnology company focused on developing innovative therapies for cancer and other diseases.  
Celldex Therapeutics, Inc uses the ticker $CLDX for trading. Listed in the [Stocks](/list/stocks) and  category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights [#](/topic/$cldx/insights)
- Celldex Therapeutics, Inc (CLDX) social dominance is up XXX% from the previous week.
- Celldex Therapeutics, Inc (CLDX) galaxy score™ is up XXXXX% from the previous week.
- Celldex Therapeutics, Inc (CLDX) posts created is up XX% from the previous week.

### Price: $XXXXX [#](/topic/$cldx/close)
---
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$cldx/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$cldx/time-series/close.tsv)  
The current price of $XXXXX appears to be influenced by positive trial data, analyst ratings, and overall biotech momentum, as well as the recent increase in engagements and posts, coupled with positive sentiment, suggesting a bullish trend, despite some concerns about volatility.  

| 24-Hour | 7-Day | 30-Day |
| ------- | ----- | ------ |
| XXXX%   | XXXX% | XXXX%  |

**1-Year High**: $XXXXX on 2024-10-22  
**1-Year Low**: $XXXXX on 2025-04-08  
  
  
### AltRank: XXX [#](/topic/$cldx/alt_rank)
---
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$cldx/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$cldx/time-series/alt_rank.tsv)  
Celldex Therapeutics, Inc (CLDX) is currently AltRank #458 based on combined combined social and market metrics
**Daily Average**: XXXXX  
**1 Week**: XXX -XXX  
**1 Month**: XXX +179  
**6 Months**: XXX +169  
**1 Year**: XXX -XXX  
**1-Year High**: XXXXX on 2025-09-04  
**1-Year Low**: XX on 2024-12-28  
  
  
### Galaxy Score: XXXXX [#](/topic/$cldx/galaxy_score)
---
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$cldx/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$cldx/time-series/galaxy_score.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XX  
**1 Week**: XX +7  
**1 Month**: XX -XX  
**6 Months**: XX -XX  
**1 Year**: XX -XX  
**1-Year High**: XX on 2025-04-11  
**1-Year Low**: X on 2025-08-28  
  
  
### Engagements: XXX [#](/topic/$cldx/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$cldx/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$cldx/time-series/interactions.tsv)  
**Current Value**: XXX  
**Daily Average**: XXXXX  
**1 Week**: XXXXXX +3.90%  
**1 Month**: XXXXXX -XX%  
**6 Months**: XXXXXXX +57%  
**1 Year**: XXXXXXXXX -XX%  
**1-Year High**: XXXXXX on 2025-06-13  
**1-Year Low**: XX on 2025-04-13  

| Social Network | X   |
| -------------- | -   |
| Engagements    | XXX |
  

  
  
### Mentions: XX [#](/topic/$cldx/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$cldx/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$cldx/time-series/posts_active.tsv)  
**Current Value**: XX  
**Daily Average**: XX  
**1 Month**: XXX -XX%  
**6 Months**: XXXXX +43%  
**1 Year**: XXXXX +56%  
**1-Year High**: XXX on 2025-06-28  
**1-Year Low**: X on 2025-04-13  

| Social Network | X  |
| -------------- | -  |
| Mentions       | XX |
  

  
  
### Creators: XX [#](/topic/$cldx/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$cldx/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$cldx/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning Celldex Therapeutics, Inc (CLDX) in the last XX hours which is down XX% from XX in the previous XX hours
**Daily Average**: XX  
**1 Month**: XX -XX%  
**6 Months**: XXXXX +129%  
**1 Year**: XXXXX +86%  
**1-Year High**: XXX on 2025-06-28  
**1-Year Low**: X on 2025-04-13  

The most influential creators that mention Celldex Therapeutics, Inc in the last XX hours

| Creator                                          | Rank | Followers | Posts | Engagements |
| -------                                          | ---- | --------- | ----- | ----------- |
| [@SteveDJacobs](/creator/twitter/SteveDJacobs)   | X    | XXXXX     | X     | XX          |
| [@semodough](/creator/twitter/semodough)         | X    | XXXXXX    | X     | XX          |
| [@MarcJacksonLA](/creator/twitter/MarcJacksonLA) | X    | XXXXX     | X     | X           |

[View More](/list/creators/$cldx/100)
  
  
### Sentiment: XX% [#](/topic/$cldx/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$cldx/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$cldx/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XXX% no change  
**1 Month**: XX% +18%  
**6 Months**: XX% -XX%  
**1 Year**: XX% +8%  
**1-Year High**: XXX% on 2024-10-20  
**1-Year Low**: XX% on 2025-02-08  

**Most Supportive Themes**
- **Positive Trial Data and Biotech Momentum:** (35%) Posts highlight positive trial data and the overall positive momentum within the biotech sector, suggesting optimism for Celldex Therapeutics.
- **Analyst Ratings and Price Targets:** (25%) Mentions of analyst ratings and price targets, with some analysts reiterating 'Buy' ratings and setting higher price targets for CLDX.
- **Product Advancements and Partnerships:** (15%) News about advancements in treatments like Dupixent and partnerships, indicating potential growth and market expansion for Celldex.
  
**Most Critical Themes**
- **Price Volatility and Market Cap Concerns:** (10%)  Some posts mention the stock's volatility and the current market cap, with one post suggesting the stock is being 'pumped' and could be a meme stock.
  
Network engagement breakdown:  
| Network | Positive | %  | Neutral | %   | Negative | %  |
| ------- | -------- | -  | ------- | -   | -------- | -  |
| X       | X        | X% | XX      | XX% | XX       | X% |
|         |          |    |         |     |          |    |
| Total   | X        | X% | XX      | XX% | XX       | X% |
  

  
  
### Social Dominance: XXXXXXX% [#](/topic/$cldx/social_dominance)
---
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$cldx/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$cldx/time-series/social_dominance.tsv)  
**Current Value**: XXXXXXX%  
**Daily Average**: XXXXX%  
**1 Week**: XXXXXXX% +0.00178%  
**1 Month**: XXXXXX% -XXXXXXXXXXXXXXXXXXXXX%  
**6 Months**: XXXXXX% -XXXXXX%  
**1 Year**: XXXXXX% -XXXXX%  
**1-Year High**: XXXXX% on 2024-10-22  
**1-Year Low**: XXXXX% on 2025-09-14  
  
  
### Market Dominance: XXXXXXX% [#](/topic/$cldx/market_dominance)
---
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$cldx/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$cldx/time-series/market_dominance.tsv)  
**Current Value**: XXXXXXX%  
**Daily Average**: X%  
**1-Year High**: XXXXX% on 2025-03-31  
**1-Year Low**: XXXXXXX% on 2025-04-09  
  
  
### Market Cap: $XXXXXXXXXXXXX [#](/topic/$cldx/market_cap)
---
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$cldx/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$cldx/time-series/market_cap.tsv)  
**Current Value**: $XXXXXXXXXXXXX  
**Daily Average**: $XXXXXXXXXXXXX  
**1 Week**: $XXXXXXXXXXXXX +$2.20%  
**1 Month**: $XXXXXXXXXXXXX +$3.50%  
**6 Months**: $XXXXXXXXXXXXX +$42%  
**1 Year**: $XXXXXXXXXXXXX -$4.90%  
**1-Year High**: $XXXXXXXXXXXXX on 2024-10-22  
**1-Year Low**: $XXXXXXXXXXXXX on 2025-04-08  

**Top assets mentioned**
In the posts about Celldex Therapeutics, Inc in the last XX hours

[Arcellx, Inc. Common Stock (ACLX)](/topic/$aclx)
[A3S Protocol (AA)](/topic/$aa)
[Alcoa, Corp. (AA)](/topic/alcoa-corp)
[Sanofi (SNY)](/topic/sanofi)
[Synthetify (SNY)](/topic/$sny)
[ATAI Life Sciences (ATAI)](/topic/atai-life)
[AAR Corp. (AIR)](/topic/$air)
[Century Aluminum Co (CENX)](/topic/$cenx)
[Tesla, Inc. (TSLA)](/topic/tesla)

**Top topics mentioned**
In the posts about Celldex Therapeutics, Inc in the last XX hours

[$abvx](/topic/$abvx), [$anab](/topic/$anab), [stocks healthcare](/topic/stocks-healthcare), [stocks bitcoin treasuries](/topic/stocks-bitcoin-treasuries), [stocks](/topic/stocks), [stocks basic materials](/topic/stocks-basic-materials), [$barcl](/topic/$barcl), [$aclx](/topic/$aclx), [upside](/topic/upside), [chronic](/topic/chronic), [stocks real estate](/topic/stocks-real-estate), [$aa](/topic/$aa), [alcoa corp](/topic/alcoa-corp), [coins arbitrum](/topic/coins-arbitrum), [stocks technology](/topic/stocks-technology), [sanofi](/topic/sanofi), [$sny](/topic/$sny), [atai life](/topic/atai-life), [$crvs](/topic/$crvs), [$cmpr](/topic/$cmpr), [$air](/topic/$air), [$cenx](/topic/$cenx), [$abeo](/topic/$abeo), [$acrs](/topic/$acrs), [$aemd](/topic/$aemd), [$allk](/topic/$allk), [$20s](/topic/$20s), [lack of](/topic/lack-of), [investment](/topic/investment), [$2412t](/topic/$2412t), [tesla](/topic/tesla), [acquisition](/topic/acquisition), [targets](/topic/targets), [$nuvb](/topic/$nuvb), [$rogsw](/topic/$rogsw), [$adpt](/topic/$adpt), [$aeis](/topic/$aeis), [$anet](/topic/$anet), [regeneron pharmaceuticals inc](/topic/regeneron-pharmaceuticals-inc), [$nvs](/topic/$nvs), [$bpmc](/topic/$bpmc), [$cnr](/topic/$cnr), [$tmo](/topic/$tmo), [boi](/topic/boi), [$zvra](/topic/$zvra), [$skin](/topic/$skin), [$alhc](/topic/$alhc), [$roiv](/topic/$roiv), [$orka](/topic/$orka), [$eltx](/topic/$eltx), [$atxs](/topic/$atxs), [$nrix](/topic/$nrix), [$atai](/topic/$atai), [$mnpr](/topic/$mnpr), [$sgmo](/topic/$sgmo), [$eypt](/topic/$eypt), [$advm](/topic/$advm), [morgan stanley](/topic/morgan-stanley), [stocks financial services](/topic/stocks-financial-services), [$clne](/topic/$clne), [coins solana ecosystem](/topic/coins-solana-ecosystem), [$adnt](/topic/$adnt), [$bmrn](/topic/$bmrn), [$arwr](/topic/$arwr), [$agio](/topic/$agio), [$alks](/topic/$alks), [$coya](/topic/$coya), [$bldax](/topic/$bldax), [$bbio](/topic/$bbio), [$ptgx](/topic/$ptgx), [$janx](/topic/$janx), [superrarebears](/topic/superrarebears), [$bldp](/topic/$bldp), [$rlay](/topic/$rlay), [$kmda](/topic/$kmda)

### Top Social Posts [#](/topic/$cldx/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Triple Digit Upside Calls Today $BLDP with XXX% upside 🚀 $RLAY $KMDA $CLDX all showing 100%+ potential 💯 $APLD riding AI wave with XX% target 🤖 Analysts going big #StocksRunner #TradingView #Upside"  
[X Link](https://x.com/stocks_runner/status/1978205007037047056) [@stocks_runner](/creator/x/stocks_runner) 2025-10-14T21:03Z XX followers, XXX engagements


"$CLDX -Barclays initiates Celldex Therapeutics coverage at Underweight due to concerns about limited upside potential through year-end 2026 -Sets $XX target"  
[X Link](https://x.com/MarcJacksonLA/status/1977784333625893102) [@MarcJacksonLA](/creator/x/MarcJacksonLA) 2025-10-13T17:11Z 7575 followers, XXX engagements


"$ABVX $ANAB $CLDX $CRVS $MNPR $ORKA $RAPT $TVRD Barclays initiates coverage on U.S. small & mid-cap biotech stocks"  
[X Link](https://x.com/MarcJacksonLA/status/1977764343845413306) [@MarcJacksonLA](/creator/x/MarcJacksonLA) 2025-10-13T15:52Z 7575 followers, XXX engagements


"Barclays - new #Biotech analyst Etzer Darout - was at BMO now at Barclays New Coverage Offers Opportunity to Participate in Biotech Upside Opportunities Abound as We Look to Next Waves of Innovation in Biotech. initiate coverage on $ABVX $ANAB $CLDX $CRVS MNPR ORKA RAPT and TVRD"  
[X Link](https://x.com/semodough/status/1977747538695295472) [@semodough](/creator/x/semodough) 2025-10-13T14:45Z 41.5K followers, 8095 engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Celldex Therapeutics, Inc Graphic Celldex Therapeutics, Inc (CLDX)

Barclays initiates coverage on Celldex Therapeutics with an Underweight rating and a $XX target. Despite the negative rating, positive trial data and analyst ratings are driving a bullish sentiment.

About Celldex Therapeutics, Inc

Celldex Therapeutics, Inc. (CLDX) is a biotechnology company focused on developing innovative therapies for cancer and other diseases.
Celldex Therapeutics, Inc uses the ticker $CLDX for trading. Listed in the Stocks and category within the Healthcare sectors.

Insights #

  • Celldex Therapeutics, Inc (CLDX) social dominance is up XXX% from the previous week.
  • Celldex Therapeutics, Inc (CLDX) galaxy score™ is up XXXXX% from the previous week.
  • Celldex Therapeutics, Inc (CLDX) posts created is up XX% from the previous week.

Price: $XXXXX #

Price Line Chart
Price 24-Hour Time-Series Raw Data
The current price of $XXXXX appears to be influenced by positive trial data, analyst ratings, and overall biotech momentum, as well as the recent increase in engagements and posts, coupled with positive sentiment, suggesting a bullish trend, despite some concerns about volatility.

24-Hour 7-Day 30-Day
XXXX% XXXX% XXXX%

1-Year High: $XXXXX on 2024-10-22
1-Year Low: $XXXXX on 2025-04-08

AltRank: XXX #

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Celldex Therapeutics, Inc (CLDX) is currently AltRank #458 based on combined combined social and market metrics Daily Average: XXXXX
1 Week: XXX -XXX
1 Month: XXX +179
6 Months: XXX +169
1 Year: XXX -XXX
1-Year High: XXXXX on 2025-09-04
1-Year Low: XX on 2024-12-28

Galaxy Score: XXXXX #

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX +7
1 Month: XX -XX
6 Months: XX -XX
1 Year: XX -XX
1-Year High: XX on 2025-04-11
1-Year Low: X on 2025-08-28

Engagements: XXX #

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
1 Week: XXXXXX +3.90%
1 Month: XXXXXX -XX%
6 Months: XXXXXXX +57%
1 Year: XXXXXXXXX -XX%
1-Year High: XXXXXX on 2025-06-13
1-Year Low: XX on 2025-04-13

Social Network X
Engagements XXX

Mentions: XX #

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1 Month: XXX -XX%
6 Months: XXXXX +43%
1 Year: XXXXX +56%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-04-13

Social Network X
Mentions XX

Creators: XX #

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Celldex Therapeutics, Inc (CLDX) in the last XX hours which is down XX% from XX in the previous XX hours Daily Average: XX
1 Month: XX -XX%
6 Months: XXXXX +129%
1 Year: XXXXX +86%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-04-13

The most influential creators that mention Celldex Therapeutics, Inc in the last XX hours

Creator Rank Followers Posts Engagements
@SteveDJacobs X XXXXX X XX
@semodough X XXXXXX X XX
@MarcJacksonLA X XXXXX X X

View More

Sentiment: XX% #

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% no change
1 Month: XX% +18%
6 Months: XX% -XX%
1 Year: XX% +8%
1-Year High: XXX% on 2024-10-20
1-Year Low: XX% on 2025-02-08

Most Supportive Themes

  • Positive Trial Data and Biotech Momentum: (35%) Posts highlight positive trial data and the overall positive momentum within the biotech sector, suggesting optimism for Celldex Therapeutics.
  • Analyst Ratings and Price Targets: (25%) Mentions of analyst ratings and price targets, with some analysts reiterating 'Buy' ratings and setting higher price targets for CLDX.
  • Product Advancements and Partnerships: (15%) News about advancements in treatments like Dupixent and partnerships, indicating potential growth and market expansion for Celldex.

Most Critical Themes

  • Price Volatility and Market Cap Concerns: (10%) Some posts mention the stock's volatility and the current market cap, with one post suggesting the stock is being 'pumped' and could be a meme stock.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X X X% XX XX% XX X%
Total X X% XX XX% XX X%

Social Dominance: XXXXXXX% #

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXX%
1 Week: XXXXXXX% +0.00178%
1 Month: XXXXXX% -XXXXXXXXXXXXXXXXXXXXX%
6 Months: XXXXXX% -XXXXXX%
1 Year: XXXXXX% -XXXXX%
1-Year High: XXXXX% on 2024-10-22
1-Year Low: XXXXX% on 2025-09-14

Market Dominance: XXXXXXX% #

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-03-31
1-Year Low: XXXXXXX% on 2025-04-09

Market Cap: $XXXXXXXXXXXXX #

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXX +$2.20%
1 Month: $XXXXXXXXXXXXX +$3.50%
6 Months: $XXXXXXXXXXXXX +$42%
1 Year: $XXXXXXXXXXXXX -$4.90%
1-Year High: $XXXXXXXXXXXXX on 2024-10-22
1-Year Low: $XXXXXXXXXXXXX on 2025-04-08

Top assets mentioned In the posts about Celldex Therapeutics, Inc in the last XX hours

Arcellx, Inc. Common Stock (ACLX) A3S Protocol (AA) Alcoa, Corp. (AA) Sanofi (SNY) Synthetify (SNY) ATAI Life Sciences (ATAI) AAR Corp. (AIR) Century Aluminum Co (CENX) Tesla, Inc. (TSLA)

Top topics mentioned In the posts about Celldex Therapeutics, Inc in the last XX hours

$abvx, $anab, stocks healthcare, stocks bitcoin treasuries, stocks, stocks basic materials, $barcl, $aclx, upside, chronic, stocks real estate, $aa, alcoa corp, coins arbitrum, stocks technology, sanofi, $sny, atai life, $crvs, $cmpr, $air, $cenx, $abeo, $acrs, $aemd, $allk, $20s, lack of, investment, $2412t, tesla, acquisition, targets, $nuvb, $rogsw, $adpt, $aeis, $anet, regeneron pharmaceuticals inc, $nvs, $bpmc, $cnr, $tmo, boi, $zvra, $skin, $alhc, $roiv, $orka, $eltx, $atxs, $nrix, $atai, $mnpr, $sgmo, $eypt, $advm, morgan stanley, stocks financial services, $clne, coins solana ecosystem, $adnt, $bmrn, $arwr, $agio, $alks, $coya, $bldax, $bbio, $ptgx, $janx, superrarebears, $bldp, $rlay, $kmda

Top Social Posts #

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"Triple Digit Upside Calls Today $BLDP with XXX% upside 🚀 $RLAY $KMDA $CLDX all showing 100%+ potential 💯 $APLD riding AI wave with XX% target 🤖 Analysts going big #StocksRunner #TradingView #Upside"
X Link @stocks_runner 2025-10-14T21:03Z XX followers, XXX engagements

"$CLDX -Barclays initiates Celldex Therapeutics coverage at Underweight due to concerns about limited upside potential through year-end 2026 -Sets $XX target"
X Link @MarcJacksonLA 2025-10-13T17:11Z 7575 followers, XXX engagements

"$ABVX $ANAB $CLDX $CRVS $MNPR $ORKA $RAPT $TVRD Barclays initiates coverage on U.S. small & mid-cap biotech stocks"
X Link @MarcJacksonLA 2025-10-13T15:52Z 7575 followers, XXX engagements

"Barclays - new #Biotech analyst Etzer Darout - was at BMO now at Barclays New Coverage Offers Opportunity to Participate in Biotech Upside Opportunities Abound as We Look to Next Waves of Innovation in Biotech. initiate coverage on $ABVX $ANAB $CLDX $CRVS MNPR ORKA RAPT and TVRD"
X Link @semodough 2025-10-13T14:45Z 41.5K followers, 8095 engagements

Celldex Therapeutics, Inc (CLDX)
/topic/$cldx